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Abstract 
 
Background: Centaurea aegyptiaca L (Asteraceae), is one of the most attractive plants growing wildly in Sinai, and is not well 
investigated for its phytochemical constituents. This study represents the first in-depth characterization of the phenolic profile of the 
aerial parts of C. aegyptiaca methanolic extract utilizing liquid chromatography (LC) combined with electrospray ionization (ESI) 
tandem mass spectrometry (MS/MS).  
Material and Methods: Phenolic profile was researched utilizing LC-HRESI-MS-MS. Assessment of cytotoxic activity against four 
human cancer cell lines (Hep-G2; hepatocellular carcinoma cells, MCF-7; breast adenocarcinoma cells, and HCT-116; colon 
carcinoma and HELA; cervical carcinoma cells) was performed using 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium 
bromide (MTT) assay. Antiviral activity was surveyed utilizing cytopathic effect inhibition assay. 
Results: A total of sixty-one compounds were tentatively distinguished (twenty-one phenolic acids and their derivatives, thirty-one 
flavonols and nine flavones) in the negative and positive modes. Centaurea aegyptiaca demonstrated outstanding results against 
Hep-G2, MCF-7, HCT-116 and HELA cell lines with IC50 of 12.1, 30.9, 11.7 and 19.5 µg/mL respectively compared and 
doxorubicin as a reference drug. Weak antiviral activity was seen against hepatitis A virus (HAV) and no impact against herpes 
simplex virus type 1 (HSV 1). 
Conclusion: This study provides a better understanding of the chemistry of C. aegyptiaca that announces itself as a promising 
cytotoxic agent. 
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Introduction 
 
 The Asteraceae (Compositae) is the biggest family of flowering plants with more than 24000 - 30000 species and 1600 - 
1700 genera, distributed worldwide aside from Antarctica with an observable financial and medicinal contribution (Funk et. al, 
2005). 
 Centaurea, the fourth biggest genus in the family Asteraceae, consists of 600 species around the world, especially in 
Mediterranean regions and in Western Asia, (Garcia-Jacas et al, 2000). Around 13 species of Centaurea are growing in Egypt. 
Centaurea species, have been the object of various phytochemical studies, with a diversity of bioactive phytochemicals and 
prevalence of flavonoids (Flamini et al., 2001; Shoeb et al., 2007; Seghiri et al, 2009) and sesquiterpene lactones (Koukoulitsa et al., 
2002; 2005). Centaurea species are claimed for their uses in gastrointestinal and inflammatory disorders, hypotensive and cytotoxic 
activities, in addition to the anti-bacterial impacts alone or when mixed with different plants (Farrag et al., 1993; Kargıoglu et al, 
2010; Köse et al., 2007). Centaurea aegyptiaca (Centaurea cancellata Sieber ex Spreng., Calcitrapa aegyptiaca (L.) Sweet, C. 
iberica) is growing wild in Sinai (St. Katherine), Egyptian eastern desert, the Red Sea coastal strip, and Gebel Elba. Investigations of 
C. aegyptiaca revealed the presence of guaianolide (Orabi et al, 2013; Sarg et al, 1987) which showed potential cytotoxic activities 
against liver and larynx carcinoma cell lines. The studies on this species deal basically with sesquiterpene lactones, while flavonoids 
are not well investigated. 
 Due to scarcity of information regarding the chemical composition of C. aegyptiaca, it is valuable to carry out an in-depth 
phytochemical investigation on this plant to characterize its main active constituents utilizing HPLC-MS-MS analysis and Xcalibur 
software with the screening of its cytotoxic and antiviral activities. 
 
Plant Material 
 
 Aerial parts of Centaurea aegyptiaca L. were gathered during the flowering stage in February 2015 from km 67, Cairo-
Suez road, Egypt. The plant was identified by Prof. Dr. Abdel-haleem Abdel-mogaly, Department of Plant Taxonomy, Herbarium of 
Horticultural Research Institute, Agricultural Research Center, Dokki, Cairo, Egypt. A voucher specimen (RS013) was deposited in 
Herbarium of Faculty of Pharmacy, October University of Modern Sciences and Arts. 
 
Material and Methods 
Preparation of the plant extract  
 
 Three hundred grams of plant material were exhaustively extracted with methanol. The combined methanolic extracts 
(CME) were filtered, concentrated under vacuum at 50°C, dried and left for LC-HRESI-MS-MS analysis, and to evaluate the 
cytotoxic and antiviral activities. 
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Cytotoxic activity 
 
 The viability of control and treated cells were explored at the Regional Center for Mycology and Biotechnology (RCMB) 
at Al-Azhar University. The CME was tested against the following human tumor cell lines: hepatocellular carcinoma (HepG-2), 
breast adenocarcinoma (MCF-7), colorectal carcinoma (HCT-116), cervix adenocarcinoma (HELA) utilizing MTT (3-(4, 5-
dimethylthiazolyl-2)- 2, 5-diphenyltetrazolium bromide) test in triplicate (Fotakis and Timbrell, 2006). Untreated cells represented 
the negative control while doxorubicin was the positive control. The absorbance was measured at 570 nm using a microplate ELISA 
reader (Sun Rise TECAN, Inc, USA). The absorbance of untreated cells was considered as 100%. The results were determined by 
three independent experiments (Wilson, 2000).  
 The percentage cell viability was calculated with the Microsoft Excel®.  Percentage cell viability was calculated as 
follows: % Cell viability = (Mean Abs control – Mean Abs test metabolite X 100)/ Mean Abs control                                                                         
Where: Abs: absorbance at 570 nm 
 The graphic plots were used for estimation of the 50% inhibitory concentration (IC50). STATA statistical analysis package 
was used for the dose response curve drawing in order to figure IC50. 
 
Antiviral activity 
 
 Cytopathic effect inhibition assay was performed following Hu and Hsiung, (1989). The cultures were treated with two 
fold serial dilutions of C. aegyptiaca extract.   Six wells were utilized for every concentration of C. aegyptiaca extract. Untreated 
vero cells in absence of CME represented the control. Inverted microscope was used for watching the virus in the control wells every 
24hr until complete viral-induced cytopathic effects (CPE). Antiviral activity was evaluated by the inhibition of cytopathic effect in 
comparison with control where scoring of the protection level offered by Centaurea extract was estimated (Vijayan et al., 2004). The 
experiment was performed thrice. Acyclovir, the treatment clinically used for herpetic viral disease, was utilized as a positive control 
(Dargan, 1998). 
 
LC-HRESI-MS-MS apparatus 
 
 The study was performed on a Bruker micro-TOF-Q Daltonics (API) Time-of-Flight mass spectrometer (Bremen, 
Germany), coupled to 1200 series HPLC system (Agilent Technologies, Waldbronn, Germany), equipped with a high-performance 
auto-sampler, binary pump, and PDA detector G 1314 C (SL). Chromatographic separation was performed on a Superspher 100 RP-
18 (75 × 4mm i.d.; 4 ߤm) column (Merck, Darmstadt, Germany). 
Table 1: Phenolic acids and their derivatives tentatively identified in Centaurea aegyptiaca 
 Rt (min.) [M-H]-m/z Fragment ions Tentatively identified 
compound 
Ref. 
1 1.68 
 
341.11 
 
179.08 (-162) 161.17 143.09 119.09 
113.04 
Caffeoyl hexoside  Dartora et al, 2011 
2 3.26 191.06 111.01 173.16 127.10 85.05 Quinic acid Dartora et al, 2011 
3 3.59 493.16 191.21 330.43 402.4 473.24 Quinic acid derv  
4 8.54 315.07 153.07  (-162) 165.14 135.19 109.09 
225.2 (-90) 195.05 (-120) 
Protocatechuic acid hexoside Chen et al, 2012 
Vallverdu-Queralt et al., 
2015 
5 9.27 515.14 179.06 353.23 341.17 191.08 Dicaffeoyl quinic acid Chen et al, 2012 
6 12.45 353.09 
 
 
191.11 179.13 135.15 Chlorogenic acid  
Dicaffeoyl quinic acid 
Dartora et al, 2011 
7 14.90 285.06 153.10 109.18 Protocatechiuc acid pentoside  
8 14.91 447.12 315.21 411.22 271.25 152.18 163.10 
179.15  
Protocatechiuc acid pentoside 
hexoside 
 
9 23.52 499.15 191.15 337.26 3 caffeoyl 5 coumaroyl quinic 
acid 
Jaiswal et al, 2010 
10 15.31 337.09 163.14 3-p-Coumaroyl quinic acid Jaiswal et al, 2010 
11 24.30 337.09 173.08 4p-Coumaroyl quinic acid Jaiswal et al, 2010 
12 19.64 529.16 173.13 191.11 367.21 355.21 4-Feruloyl 5caffeoylquinic 
acid isomer 
Jaiswal et al 2010 
13 21.54 
 
21.69 
447.11 152.12 401.19 285.26 241.24 163.16 
177.2 
401.26 285.18 152.15 163.16 
Protocatechuic acid hexoside 
pentoside 
 
14 21.96 193.05 134.11 149.07 Ferulic acid Vallverdu-Queralt et al., 
2015 
15 22.25 417.10 241.18 152.07 285.22 163.15 179.15 Dihydroxybenzoic  acid-O-
dipentoside 
Beelders et al, 2014 
16 23.62 529.16 173.13 193.08 4-feruloyl-5-Caffeoyl quinic 
acid 
Dartora et al, 2011; Jaiswal 
et al, 2010 
17 35.14 367.10 173.16 191.14 4-Feruloyl quinic acid Jaiswal et al, 2010 
18 42.74 367.10 191.12 173.13 193.14 5-Feruloyl quinic acid Jaiswal et al, 2010 
19 32.15 325.09 163.05 119.09 101.08 113.18 Coumaroyl hexoside Vallverdu-Queralt et al., 
2015 
20 59.68 543.21 349.21 367.20 193.22 173.13 Diferuloylquinic acid isomer  
21 60.69 473.11 311.27 341.20  Dicaffeoyltartaric  acids 
(chicoric acids) 
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Table 2: Flavonoids tentatively identified in Centaurea aegyptiaca 
No RT [M-H]-m/z Fragment ions [M-H]+ m/z Fragment ions Tentatively identified compound Ref. 
1 38.23 563.14 473.26 [M-H-90] 443.31 [M-H-120] 
353.22 [M-H-120-90] 383.25  
 ------- Apigenin 8C-hexoside 6C-
pentoside 
Ibrahim et al., 
2015 
2 38.83 785.21 315.19 [isorh, M-H-2hexose-rh), 
623.26 [M-H-162] 477.23 (M-H-162-
146] 300.16 
787.24 625.14 [M+H-162] 479.17 [-162-
146] 317.13  
Isorhamnetin dihexoside 
rhamnoside 
 
3 40.46 479.08 317.15 [M-H-162] 357.15 481.10 319.08 [M+H-162]  Quercetagenin –O- hexoside Pajero et al., 
2004 
4 40.57 
 
 
317.16 
 
 
271.15 287.13 166.03 139.14 299.18 
243.14 227.17 179.06 
319.12  273.09 301.03 245.07 181.02 153.08 
136.37 
Quercetagenin  
5 41.36 625.14 317.16 [M-H-308] 461.25 341.18  627.16 481.18 [M+H-146] 319.14 [M+H-
146-162] 463.23 [M+H+162] 
Quercetagenin-rhamnoside-
hexoside (rutinoside) 
 
6 42.22 641.27 317.15[M-H-2hexose] 243.22 225.30 
479.35 [M-H-162] 447.23 
 ----- Quercetagenin  dihexoside  
7 44.10 639.16 477.19 [M-H-162] 315.18 [M-H-162-
162] 447.22 300.26 271.21 
641.17  479.17 [M+H-162] 317.16 [M+H-
162-162] 
Isorhamnetin –O-dihexoside Lin and 
Harnly, 2010 
8 44.36 623.13 285.15 [M-H-162-176] 447.22 [M-H-
176] 337.23 357.13 257.18 243.26 
625.14 287.12 449.17 [M+H-176]   Kaempferol hexoside glucuronide  
9 44.55 
 
463.09 301.14 
 
465.10  303.14  Quercetin -O-hexoside Vallverdu-
Queralt et al., 
2015. 
10 45.46 
 
 
301.18 
 
 
283.13 271.16 255.17 227.10 179.07 
8165.10 151.18 
303.12  285.14 273.13 179.14 169.06 137.02 Quercetin Vallverdu-
Queralt et al., 
2015. 
11 48.01 269.14 251.16 209.23 225.26 165.27 189.26 271.21 242.13 253.15 153.10 225.20 211.17  
rt48.70 
Apigenin  
12 48.31 431.10 311.22 [M-H-120] 341.25 [M-H-90] 433.11 415.16 367.16 337.14 313.17  Apigenin C-glucoside (Isovitexin) Irahim et al., 
2015. 
13 49.05 639.16 331.20 [M-H-162-146] 316.20  - Patuletin hexoside rhamnoside Parejo et al., 
2004 
14 49.08 493.10 331.16 [M-H-162]   Patuletin hexoside Parejo et al., 
2004 
15 49.10 331.05 
331.08 
316.17 317.18 [M-H-14] 333.06 318.09 301.12 155.05 169.10 Patuletin 
 
Parejo et al., 
2004 
16 49.37 623.15 315.14 300.22 271.18 625.18 479.17 [M+H-146] 317.07 [M+H-
146-162] 463.20 [M+H-162] 
Isorhamnetin 3-O-hexoside 7-O-
rhamnoside 
Stintzing et al., 
2004 
Ibrahim et al., 
2015 
17 49.51 609.18 301.18 [M-H-308] 269.14 199.22 611.19 449.10 [M+H-162] 271.11 303.13 
[M+H-146] 465.10 [quercetin+162] 
Quercetin hexoside rhamnoside  
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431.15 413.26 
18 49.73 285.19 267.11 253.27 239.12 185.13 137.06 287.13 
RT59 
269.22 259.14 241.14 213.12 164.89 
153.02 
Kaempferol Schmeda-
Hirschmann  
Et al., 2015 
19 50.52 315.05 300.20 317.07  302.11  Isorhamnetin Pajero et al., 
2004 
20 53.79 477.10 315.18 [M-H-162] 301.19 357.19 [M-
H-120] 415.35 
479.12 317.13 [M+H-162] 419.94 360.94 Isorhamnetin 3-O-hexoside Pajero et al., 
2004. 
21 50.54 593.15 285.15 [M-H-146-162] 429.28 531.28 
269.17 
595.17 287.13 [M+H-162-146] 449.11 
[M+H-146] 213.27  
Kaempferol O-hexoside-
rhamnoside 
Ibrahim et al., 
2015. 
22 53.13 477.07 301.13 [M-H-176] 415.29   Quercetin glucuronide  
23 54.10 431.10 269.18 [M-H-162] 311.16 [M-H-120] 433.11 271.10 [M+H-162] 415.21 Apigenin hexoside  
24 54.5 461.11 299.19 [M-H-162] 339.17  --- Hispidulin hexoside Akkal et al., 
2003 
25 55.91 593.28 269.29 [M-H-162-162] 431.36 [M-H-
162] 417.36 285.24 245.27 225.20 
595.30 577.22 [M+H-18] 415.16 [M+H-
180] 253.21 235.20 325.14 271.27 
Apigenin -O- dihexoside  
26 56.13 521.09 317.16 [M-H-204] 399.29 429.21 523.11 319.09 [M+H-204] 503.25 455.14 Quercetagenin acetyl hexoside Parejo et al., 
2004 
27 56.95 505.10 301.16 [M-H-204] 343.21 [M-H-162] 
461.30 [M-H-44] 179.09 151.13 
507.11 303.12 [M+H-204] 385.22 447.23 
[M+H-60] 
Quercetin acetyl hexoside Oszmiański et 
al., 2015 
28 57.03 491.20 476.28 [M-H-15] 315.23 [M-H-176] 
329.22 [M-H-162] 431.32 [M-H-60] 
175.16 161.12 
  Isorhamnetin glucuronide  
29 58.59 607.26 269.27 [M-H-176-162] 431.37 [M-H-
176] 383.21 353.16   
609.28 253.08 235.14 429.03 [M+H-180] 
431.28  
Apigenin glucuronide hexoside  
30 58.70 461.07 285.18 219.23 175.11 339.24 461.09 287.13 [M+H-176] 445.24 [M+H-
18] 175.07 
Kaempferol gucuronide Schmeda-
Hirschmann  
Et al., 2015 
31 59.03 625.12 463.19 [M-H-162] 315.15 301.19 [M-
H-162-162] 
  Quercetin 3, 7 di-O-hexoside Ibrahim et al., 
2015. 
32 61.34 447.09 327.14 [M-H-120] 357.06 [M-H-90] 
387.31 [M-H-60] 285.29 429.28 
241.25 175.16 
449.11 287.13 431.19 383.12 329.17 276.17 
246.19 
Luteolin C-hexoside Brito et al., 
2014 
33 61.87 491.21 285.16 473.36 431.41 [M-H-60] 
315.24 [M-H-176] 329.33 [M-H-162] 
175.13 179.18 167.19  
493.23 33.13 475.29 [M+H-15] 269 155.05  Kaempferol methyl ether 
glucuronic acid 
Schmeda-
Hirschmann  
Et al., 2015 
34 62.41 535.11 331.19 [M-H-204] 373.09 [M-H-162] 
471.31 [M-H-62] 
537.23 478.98 333.18 [M+H-204] 419.88 
375.31 [M+H-162]  
Patuletin acetyl hexoside  
35 63.18 519.11 315.23 [M-H-204] 357.36 [M-H-162] 521.13 317.12 [M+H-204] 501.27 359.34 
[M+H-162] 
Isorhamnetin acetyl hexoside  
36 63.76 639.17 519.27 [M-H-120] 549.24 [M-H-90] 
607.34 [M-H-32] 463.22 [M-H-176] 
 --- Quercetin C-hexoside glucuronide  
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301.21 [M-H-176-162] 219.17 
37 64.24 521.33 359.45 [M-H-162] 503.39 [M-H-18] 
489.26 [M-H-32] 475.22 341.44 
315.21  
523.35 343.13 [M+H-180] 361.13 [M+H-
162] 505.21 [M+H-18] 318.14 
325.13 307.23  
Centaurein (jaceidin hexoside) 
 
Flamini et al., 
2001 
38 68.03 299.06 284.06 [M-H-15] 301.07 286.09 [M+H-15] 147.11 129.12 Hispidulin Flamini et al., 
2001 
39 69.35 507.35 345.41 [M-H-162] 331.10 299.35 
161.19 417.41 
509.13 347.17 [M+H-162] 303.12 449.17 
[M+H-60] 
Axillarin hexoside Parejo et al., 
2004 
40 74.61 609.41 315.27 [M-H-162-132] 293.34 246.23 
225.09 447.39 [M-H-162] 
 -- Isorhamnetin hexoside pentoside  
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Identification of Phenolic Compounds  
 
 Centaurea aegyptiaca CME was investigated following Hassaan et al, (2014). The mobile phase consists of two solvents, 
(A) 2% acetic acid (pH 2.6) and (B) 80% methanol. Gradient elution was used at a flow rate of 100 ߤL/min, from 5% to 50% B at 
30°C. Ion spray (pneumatically assisted electrospray) ionization system was utilized. Spectra were recorded in positive and negative 
ion mode between m/z 120 and 1,500 with capillary voltage, 4000V and heated dry nitrogen gas temperature, 200°C and flow rate 10 
L/min. The gas flow to the nebulizer was set at pressure 1.6 bar. For collision-induced dissociation (CID) MS-MS estimations, the 
voltage over the collision cell ranged between 20 to 70 eV. Argon was utilized as collision gas. Sodium formate was utilized for 
calibration toward the end of LC-MS run. Interpretation for ESI-MS was performed by Xcalibur 2.1 software from Thermo 
Scientific (Berlin, Germany). 
 
Results 
Phenolics identified 
 
 The phytochemical fingerprint of C. aegyptiaca was determined using an LC-HRESI-MS-MS. Analyses were carried out 
by using a full scan and MS2 data-dependent operative mode. 
 The combination of ESI positive and negative modes permitted the tentative identification of a total of sixty-one 
compounds by the interpretation of their fragmentation patterns combined with the available literature information. Twenty-one 
phenolic acid and their derivatives have been identified in the negative mode only (Table 1), while thirty-one flavonol and nine 
flavones were tentatively identified based on their MS/MS fragmentation in the negative and positive modes and listed in table 2.   
 
Cytotoxic activity 
 
 Centaurea aegyptiaca CME was investigated against four human cell carcinoma (HepG-2, MCF-7, HCT-116, and HELA) 
using MTT assay. The higher potency was observed with HCT-116 followed by HepG-2 then HELA cells (Table 3) with IC50 less 
than 20 µg/mL compared with doxorubicin as a standard cytotoxic agent with a range of 0.46-0.23 µg/mL.  
 
Table 3: Cytotoxic activity of Centaurea aegyptiaca  extract 
 
Cell line HepG-2 MCF-7 HCT-116 HELA 
 CME Dox CME Dox CME Dox CME Dox 
IC50 
(µg/mL) 12.1 ± 3.89 
0.467 ± 0.2 
 30.9 ± 2.62 0.426 ± 0.35 11.7 ± 1.44 0.23 ± 0.17 
19.5± 
2.73 
0.456± 0.35 
(CME) and Doxorubicin standard (Dox) against hepatocellular carcinoma cells (Hep-G2), Human breast adenocarcinoma cells 
(MCF-7), colon carcinoma cells (HCT-116) and cervical cell carcinoma (HELA) 
 
Antiviral activity 
 
 Centaurea aegyptiaca CME exhibited weak antiviral activity against hepatitis A virus (HAV), and no effect was observed 
with herpes simplex virus type 1(HSV 1). 
 
 
Discussion 
 
 Liquid chromatography/tandem mass spectrometry (LC/MS/MS), represents the most popular technique used to unravel 
the complexity of phenolic compounds. Those non-volatile, polar and thermally labile compounds are found as complex mixtures in 
plants [Parejo et al., 2004]. Centaurea aegyptiaca has not been studied for its phenolic content before. 
 
Phenolic acids and their derivatives 
 
 Chlorogenic acids (CGAs) are a group of esters formed between a quinic acid and certain trans-cinnamic acids, most 
commonly caffeic, p-coumaric, and ferulic acid (Clifford et al, 2006).  
The neutral loss of 162, 132, 146, 176 mass units revealed the presence of compounds with a hexose (galactose or glucose), pentose 
(arabinose or xylose), deoxyhexose (rhamnose) and glucuronic acid unit, respectively (Cuyckens and Claeys 2004). 
Compound 1 was identified as caffeoyl hexoside with base peak 179, while compound 2 was tentatively identified as 
quinic acid (MS2 at m/z 111, 173). Many derivatives were assigned as dicaffeoyl quinic acid (compound 5; MS2 at m/z 191, 353), 
chlorogenic acid (compound 6; MS2 at m/z 191, 179), caffeoyl coumaroyl quinic acid (compound 9; MS2 173, 191), 4 and 5 p-
coumaroyl quinic acid (compounds 10 and 11; 163, 191 respectively) in addition to several isomers of Feruloyl caffeoyl quinic acid 
with various fragmentation pattern (compound 12 and 16). Phenolic acid glycosides, such as protocatechuic acid hexoside 
(compound 4), protocatechuic acid pentoside (compound 7) and protocatechuic acid pentoside hexoside (compound 8), giving the 
corresponding fragments for the loss of a hexose [M-H-162], a pentose [M-H-132] and the consecutive loss of both. In addition, 
coumaric acid hexosides (compound 19) was identified based on the fragments at m/z 163 (loss of a hexose moiety) and the typical 
fragment of coumaric acid at m/z 119 (Fischer et al., 2011). Compound 15 was assigned as dihydroxybenzoic pattern previously 
reported with the same fragmentation pattern and attempted to be protocatechuic acid dipentoside. Many isomers of feruloyl quinic 
acid have been identified with different fragmentation pattern (Compound 17 and 18; MS2 173 and 191 respectively) (Table 1). 
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Flavonoid glycosides 
 
 Based on previous information concerning Centaurea genus, methoxylated derivatives of flavone and flavonol glycosides 
were expected. Through this study, C.aegyptiaca was claimed as a rich source of flavonoids. In the MS identification of C-
glycosides, the key fragmentations utilized were [M-H-60]-, [M-H-90]-and [M-H-120]-. 
 Apigenin and hispidulin that were previously identified in Centaurea furfuracea (Akkal et al., 2003) represented the 
principle identified flavones. Compounds 1, 11, 12, 23, 25 and 29 were tentatively identified as apigenin derivatives with [A-H]-at 
m/z 269.14 and characteristic peaks at m/z 225 and 209. Compounds 12 and 23 were tentatively identified as Apigenin 8C-glycoside 
and 6C-glycoside, while compounds 24 and 37 were identified as hispidulin hexoside, and hispidulin, respectively. 
 Methoxylated flavonol represented the majority of identified flavonols including isorhamnetin and patuletin derivatives in 
addition to jaceidin, axillarin. Compound 2, with a [M-H]-at m/z 785 and MS2 ions at m/z 315 (M-324, - dihexose moiety, - 
rhamnose), 623 [M-H-162]- and 477 [M-H-162-146]- was tentatively identified  as Isorhamnetin dihexoside rhamnoside. 
Quercetagenin (compound 4), with its derivatives quercetagenin O-hexoside, rutinoside, and dihexoside with loss of 162, 308 and 
324 daltons respectively were also tentatively identified (Compounds 3, 5 and 6), in addition to the acetylated derivative (compound 
26), with [M-H] at m/z 521 and MS2 at 317 and the characteristic loss of 204 denoting acetylated hexoside and tentatively identified 
as quercetagenin acetyl hexoside. Kaempferol, (compound 18), was also identified with its characteristic peak in the positive mode at 
m/z 213. Compound 8 was tentatively identified as kaempferol hexoside glucuronide with the characteristic loss of 176 in the 
positive and negative mode. Kaempferol hexoside rhamnoside was also identified with [M+H] at m/z 595 and characteristic 
fragments at m/z 287, 449 [M+H-146] and 213 (compound 21). Quercetin (Compound 10), was observed with six derivatives 
tentatively identified as quercetin-O-hexoside (compound 9), quercetin rutinoside (compound 17) with the characteristic loss of 308 
daltons, quercetin glucuronide (compound 22), quercetin dihexoside (compound 31), quercetin hexoside glucuronide (compound 36) 
and the acetylated derivative of quercetin hexoside (compound 27) with MS2 at m/z 301 [M-H-204], 343 [M-H-162] and 461 [M-H-
44]. Patuletin (compound 15) and its derivatives, patuletin hexoside (compound 14) and hexoside rhamnoside (compound 13) have 
been also identified with [A-H] 331. Acetylated hexoside derivatives (compound 34), has been also identified with [M-H] at m/z 535 
and base peak 331 [M-H-204] and characteristic fragment at m/z 373 [M-H-162]. Centaurein (compound 37), was tentatively 
identified with [M-H] at m/z 521 and characteristic fragments at 359 [M-H-162] indicating its aglycone jaceidin. Patuletin and 
Centaurein were previously identified in Centaurea species (Akkal et al., 2003; Flamini et al., 2001). 
 Acetylated derivatives have been reported before as, quercetin 3-O-[(2,3,4-triacetyl-α-rhamnopyranosyl)1'''→6''] 3-acetyl-
β-galactopyranoside and quercetin 3-O-[(2,3,4-triacetyl-α-rhamnopyranosyl)1'''→6'']-4-acetyl-β-galactopyranoside from Gentiana 
spicata, a descendant from Centaurea family (Handoussa et al., 2009). 
 
Cytotoxic activity  
 
 When the IC50 value in carcinoma cells, after incubation between 48 and 72 hrs, is under 20 μg/mL, the cytotoxic activity 
was commonly considered (Boik, 2001). C. aegyptiaca CME demonstrated significant activity against colorectal and hepatocellular 
carcinoma. This promising cytotoxic action was related to the increased number of OH groups and presence of 3'- OMe as reported 
by Jeong et al. (2007). Cytotoxic activity was previously reported in various Centaurea species because of phenolic, flavonoid and 
sesquiterpene contents (Erol-Dayi et al., 2011, Medjroubi et al., 2005, Shoeb et al., 2007, Saroglou et al., 2005 and Ahmed et al, 
2014). 
 
Conclusion 
 
Centaurea aegyptiaca is a rich source of phenolic and flavonoid glycosides contributing to a powerful cytotoxic activity 
that may represent a good candidate for further studies and reflects its traditional uses. 
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